ZSAN Historical Earnings image   This ZSAN historical earnings page last updated 5/23/2022
ZSAN Historical Revenue
PeriodHistorical Earnings DateGAAP
Q1 20225/13/20220.00B
Q4 20213/17/20220.09M
Q3 202111/10/20210.00B
Q2 20218/10/20210.00B
Q1 20215/12/20210.00B
Q4 20203/11/2021NA
Q3 202011/13/2020NA
Q2 20208/6/2020NA
Q1 20205/14/2020NA
Q4 20193/13/2020NA
Q3 201911/14/2019NA
Q2 20198/14/2019NA
Q1 20195/14/2019NA
Q4 20183/14/2019NA
Q3 201811/14/2018NA
Q2 20188/9/2018NA
Q1 20185/15/2018NA
Q4 20173/12/2018NA
Q3 201711/9/2017NA
Q2 20178/10/2017NA
Q1 20175/9/2017NA
Q4 20163/1/2017NA
Q3 201611/9/2016NA
Q2 20168/10/2016NA
Q1 20165/12/2016NA
Q4 20153/29/2016NA
Q3 201511/9/2015NA
Q2 20158/12/201595000
Q1 20155/11/2015218000
Q4 20143/25/20152.86M
ZSAN Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q1 20225/13/2022-1.750
Q4 20213/17/2022-2.100
Q3 202111/10/2021-2.450
Q2 20218/10/2021-2.100
Q1 20215/12/2021-2.800
Q4 20203/11/2021-2.800
Q3 202011/13/2020-3.850
Q2 20208/6/2020-4.900
Q1 20205/14/2020-8.400
Q4 20193/13/2020-16.100
Q3 201911/14/2019-19.250
Q2 20198/14/2019-19.250
Q1 20195/14/2019-27.650
Q4 20183/14/2019-29.750
Q3 201811/14/2018-23.800
Q2 20188/9/2018-26.250
Q1 20185/15/2018-145.600
Q4 20173/12/2018-133.000
Q3 201711/9/2017-140.000
Q2 20178/10/2017-119.000
Q1 20175/9/2017-238.000
Q4 20163/1/2017-322.000
Q3 201611/9/2016-364.000
Q2 20168/10/2016-378.000
Q1 20165/12/2016-476.000
Q4 20153/29/2016-448.000
Q3 201511/9/2015-504.000
Q2 20158/12/2015-441.000
Q1 20155/11/2015-329.000
Q4 20143/25/2015-1946.000
Quotes delayed 20 minutes

Email EnvelopeFree ZSAN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Zosano Pharma (ZSAN) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ZTS Past Earnings
ZY Past Earnings
ZYNE Past Earnings
ZYXI Past Earnings
A Past Earnings
AADI Past Earnings
ABBV Past Earnings
ABC Past Earnings
ABEO Past Earnings
ABIO Past Earnings
What was the record high ZSAN historical earnings result?
In terms of earnings or revenue, what is the best ZSAN historical earnings result that Zosano Pharma has ever posted, and when?

✔️Accepted answer: Within our data set, the highest ZSAN historical earnings result was set in Q1 2022, when Zosano Pharma posted results of -1.750/share. The most successful revenue quarter within our data set was Q4 2014 when Zosano Pharma reported revenue of 2.86M.

What was the lowest Zosano Pharma historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest ZSAN has reported, and when?

✔️Accepted answer: Within our data set, the lowest ZSAN historical earnings result was set in Q4 2014, when Zosano Pharma posted results of -1946.000/share. The smallest revenue quarter within our data set was Q4 2020 when Zosano Pharma reported revenue of NA.

On this page we presented the ZSAN historical earnings date information for Zosano Pharma. Reviewing that ZSAN Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2022, when ZSAN posted adjusted EPS of -1.750/share. Meanwhile the lowest ZSAN historical earnings result was in Q4 2014, when ZSAN posted adjusted EPS of -1946.000/share. Moving to Zosano Pharmas historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2014 when ZSAN reported 2.86M in revenue, while the smallest revenue quarter was Q4 2020 when ZSAN reported NA in revenue.

For self directed investors doing their due diligence on ZSAN or any other given stock, their research can benefit from looking into all of the Zosano Pharma historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Zosano Pharma historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for ZSAN. Thanks for visiting, and the next time you need to research ZSAN historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Top Ten Hedge Funds Holding ALTO, FAUS Videos, HDY Historical Stock Prices.

 

ZSAN Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.